Lapatinib, a HER2 tyrosine kinase inhibitor, induces stabilization and accumulation of HER2 and potentiates trastuzumab-dependent cell cytotoxicity
Scaltriti, M, Verma, C, Guzman, M, Jimenez, J, Parra, J L, Pedersen, K, Smith, D J, Landolfi, S, Ramon y Cajal, S, Arribas, JVolume:
28
Year:
2008
Language:
english
Pages:
12
DOI:
10.1038/onc.2008.432
File:
PDF, 537 KB
english, 2008